Average Co-Inventor Count = 3.62
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (15 from 3,684 patents)
2. Teva Pharmaceuticals Australia Pty Ltd (2 from 14 patents)
17 patents:
1. 10981986 - Fusions of antibodies to CD38 and attenuated interferon alpha
2. 10590183 - BSL2v2c2-Ig polypeptides
3. 10400023 - B7-related nucleic acids and polypeptides useful for immunomodulation
4. 10308702 - BSL2v2c2-Ig polypeptides
5. 9611322 - Fusions of antibodies to CD38 and attenuated interferon alpha
6. 9409970 - Polynucleotides encoding BSL2v2c2
7. 9399052 - Polynucleotides encoding BSL2v2c2-Ig
8. 8674076 - BSL2vcvc-lg polypeptides
9. 8664360 - BSL3 polypeptides
10. 8354513 - Polynucleotides encoding BSL2vcvc-lg
11. 8080636 - BSL3 antibodies
12. 7807786 - BSL2v1c2 polypeptides
13. 7723479 - BSL3 polypeptides
14. 7368554 - Polynucleotides encoding BSL2v1c2-Ig
15. 7358354 - Polynucleotides encoding BSL3